Clinical Trials Browser

Interventional × HER2-positive Breast Cancer × Gastrointestinal × Clear all

NCT05514717 2025-07-11

A Study of XMT-2056 in Advanced/Recurrent Solid Tumors That Express HER2

Phase 1 Recruiting

BreastGastrointestinalThoracic

HER2-positive Breast Cancer

NCT03330561 2024-04-22

PRS-343 in HER2-Positive Solid Tumors

Phase 1 Completed

BreastGastrointestinalGenitourinaryOther solid neoplasm

HER2-positive Breast Cancer

NCT03650348 2024-04-22

PRS-343 in Combination With Atezolizumab in HER2-Positive Solid Tumors

Phase 1 Completed

BreastGastrointestinalGenitourinaryOther solid neoplasm

HER2-positive Breast Cancer